IQ-AI Limited (IQAIF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 796.65 Thousand USD | -15.36% |
| 2022 | 941.26 Thousand USD | 77.27% |
| 2021 | 530.96 Thousand USD | 7.42% |
| 2020 | 494.27 Thousand USD | 78.63% |
| 2019 | 276.69 Thousand USD | -14.78% |
| 2018 | 324.67 Thousand GBP | -49.15% |
| 2017 | 638.49 Thousand GBP | 11.85% |
| 2016 | 570.87 Thousand GBP | -8.44% |
| 2015 | 623.45 Thousand GBP | 51.69% |
| 2014 | 411 Thousand GBP | -70.17% |
| 2013 | 1.37 Million GBP | 27.12% |
| 2012 | 1.08 Million GBP | -79.34% |
| 2011 | 5.24 Million GBP | -42.79% |
| 2010 | 9.17 Million GBP | 20.57% |
| 2009 | 7.6 Million GBP | -34.64% |
| 2008 | 11.63 Million GBP | -28.06% |
| 2007 | 16.17 Million GBP | -8.21% |
| 2006 | 17.62 Million GBP | 117.53% |
| 2005 | 8.1 Million GBP | 22.57% |
| 2004 | 6.61 Million GBP | -16.92% |
| 2003 | 7.95 Million GBP | -18.46% |
| 2002 | 9.75 Million GBP | -5.2% |
| 2001 | 10.29 Million GBP | -18.88% |
| 2000 | 12.68 Million GBP | -27.19% |
| 1999 | 17.42 Million GBP | -1.16% |
| 1998 | 17.63 Million GBP | 51.46% |
| 1997 | 11.64 Million GBP | 3.91% |
| 1996 | 11.2 Million GBP | 51.93% |
| 1995 | 7.37 Million GBP | 90.62% |
| 1994 | 3.86 Million GBP | 228.63% |
| 1993 | 1.17 Million GBP | -50.94% |
| 1992 | 2.39 Million GBP | -7.05% |
| 1991 | 2.58 Million GBP | 20.66% |
| 1990 | 2.13 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 811.1 Thousand USD | 0.0% |
| 2023 Q3 | 763.5 Thousand GBP | -13.97% |
| 2023 Q1 | 862.52 Thousand GBP | -8.37% |
| 2023 Q2 | 887.43 Thousand USD | 2.89% |
| 2023 Q4 | 796.65 Thousand USD | 4.34% |
| 2023 FY | 796.65 Thousand USD | -15.36% |
| 2022 Q4 | 941.26 Thousand USD | 69.15% |
| 2022 Q2 | 626.75 Thousand GBP | -7.35% |
| 2022 Q1 | 676.45 Thousand GBP | 27.4% |
| 2022 FY | 941.26 Thousand USD | 77.27% |
| 2022 Q3 | 556.46 Thousand GBP | -11.21% |
| 2021 Q3 | 529.29 Thousand GBP | 7.6% |
| 2021 Q2 | 491.88 Thousand GBP | 0.21% |
| 2021 Q1 | 490.83 Thousand GBP | -0.7% |
| 2021 FY | 530.96 Thousand USD | 7.42% |
| 2021 Q4 | 530.96 Thousand GBP | 0.32% |
| 2020 FY | 494.27 Thousand USD | 78.63% |
| 2020 Q1 | 320.26 Thousand GBP | 15.75% |
| 2020 Q2 | 318.28 Thousand GBP | -0.62% |
| 2020 Q3 | 466.56 Thousand GBP | 46.59% |
| 2020 Q4 | 494.27 Thousand GBP | 5.94% |
| 2019 Q3 | 256.82 Thousand GBP | 76.1% |
| 2019 Q4 | 276.69 Thousand GBP | 7.74% |
| 2019 Q2 | 145.83 Thousand GBP | -2.28% |
| 2019 Q1 | 149.24 Thousand GBP | -41.46% |
| 2019 FY | 276.69 Thousand USD | -14.78% |
| 2018 Q1 | 404.08 Thousand GBP | 292.52% |
| 2018 Q3 | 332.24 Thousand GBP | 15.36% |
| 2018 FY | 324.67 Thousand GBP | -49.15% |
| 2018 Q4 | 254.92 Thousand GBP | -23.27% |
| 2018 Q2 | 288 Thousand GBP | -28.73% |
| 2017 Q1 | 586.39 Thousand GBP | 1027.68% |
| 2017 Q4 | 102.94 Thousand GBP | -25.36% |
| 2017 Q3 | 137.92 Thousand GBP | -70.53% |
| 2017 FY | 638.49 Thousand GBP | 11.85% |
| 2017 Q2 | 468 Thousand GBP | -20.19% |
| 2016 Q2 | 382 Thousand GBP | -30.57% |
| 2016 Q1 | 550.19 Thousand GBP | 48.7% |
| 2016 FY | 570.87 Thousand GBP | -8.44% |
| 2016 Q4 | 52 Thousand GBP | -22.86% |
| 2016 Q3 | 67.41 Thousand GBP | -82.35% |
| 2015 Q4 | 370 Thousand GBP | -33.91% |
| 2015 Q1 | 485.8 Thousand GBP | 18.2% |
| 2015 FY | 623.45 Thousand GBP | 51.69% |
| 2015 Q2 | 327 Thousand GBP | -32.69% |
| 2015 Q3 | 559.88 Thousand GBP | 71.22% |
| 2014 Q3 | 668.12 Thousand GBP | -57.87% |
| 2014 FY | 411 Thousand GBP | -70.17% |
| 2014 Q4 | 411 Thousand GBP | -38.48% |
| 2014 Q1 | 2.63 Million GBP | 91.23% |
| 2014 Q2 | 1.58 Million GBP | -39.81% |
| 2013 Q3 | 2.22 Million GBP | 69.19% |
| 2013 FY | 1.37 Million GBP | 27.12% |
| 2013 Q1 | 1.99 Million GBP | 83.9% |
| 2013 Q2 | 1.31 Million GBP | -34.08% |
| 2013 Q4 | 1.37 Million GBP | -38.01% |
| 2012 Q4 | 1.08 Million GBP | 0.0% |
| 2012 Q2 | 3.53 Million GBP | 0.0% |
| 2012 FY | 1.08 Million GBP | -79.34% |
| 2011 Q4 | 5.24 Million GBP | 0.0% |
| 2011 FY | 5.24 Million GBP | -42.79% |
| 2011 Q2 | 8.28 Million GBP | 0.0% |
| 2010 Q4 | 9.17 Million GBP | 0.0% |
| 2010 FY | 9.17 Million GBP | 20.57% |
| 2010 Q2 | 5.45 Million GBP | 0.0% |
| 2009 FY | 7.6 Million GBP | -34.64% |
| 2009 Q4 | 7.6 Million GBP | 0.0% |
| 2008 FY | 11.63 Million GBP | -28.06% |
| 2007 FY | 16.17 Million GBP | -8.21% |
| 2006 FY | 17.62 Million GBP | 117.53% |
| 2005 Q4 | 8.1 Million GBP | 0.0% |
| 2005 FY | 8.1 Million GBP | 22.57% |
| 2005 Q2 | 4.85 Million GBP | 0.0% |
| 2004 Q4 | 6.61 Million GBP | 0.0% |
| 2004 Q2 | 5.58 Million GBP | 0.0% |
| 2004 FY | 6.61 Million GBP | -16.92% |
| 2003 FY | 7.95 Million GBP | -18.46% |
| 2002 FY | 9.75 Million GBP | -5.2% |
| 2001 FY | 10.29 Million GBP | -18.88% |
| 2000 FY | 12.68 Million GBP | -27.19% |
| 1999 FY | 17.42 Million GBP | -1.16% |
| 1998 FY | 17.63 Million GBP | 51.46% |
| 1997 FY | 11.64 Million GBP | 3.91% |
| 1996 FY | 11.2 Million GBP | 51.93% |
| 1995 FY | 7.37 Million GBP | 90.62% |
| 1994 FY | 3.86 Million GBP | 228.63% |
| 1993 FY | 1.17 Million GBP | -50.94% |
| 1992 FY | 2.39 Million GBP | -7.05% |
| 1991 FY | 2.58 Million GBP | 20.66% |
| 1990 FY | 2.13 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Achiko AG | 6.49 Million USD | 87.742% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.37 Million USD | 90.485% |
| Cannabis Sativa, Inc. | 1.26 Million USD | 36.931% |
| CompuMed, Inc. | 1.34 Million USD | 40.781% |
| CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 99.945% |
| Cogstate Limited | 16.91 Million USD | 95.291% |
| CareView Communications, Inc. | 40.52 Million USD | 98.034% |
| Craneware plc | 215.06 Million USD | 99.63% |
| Caduceus Software Systems Corp. | 5.57 Million USD | 85.71% |
| Certive Solutions Inc. | 10.95 Million USD | 92.729% |
| Drug Free Solution, Inc. | 333.29 Thousand USD | -139.022% |
| DATATRAK International, Inc. | 6.18 Million USD | 87.11% |
| Strainsforpains, Inc. | 2.61 Million USD | 69.485% |
| Healixa Inc. | 10.57 Million USD | 92.466% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 138.29 Thousand USD | -476.078% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 1.02 Million USD | 22.089% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5068.58 USD | -15617.578% |
| iCoreConnect Inc. | 11.24 Million USD | 92.914% |
| Cannabiz Mobile, Inc. | 559.05 Thousand USD | -42.502% |
| Mednow Inc. | 9.46 Million USD | 91.587% |
| Galileo Life Sciences, Inc. | 725.46 Thousand USD | -9.813% |
| MediXall Group, Inc. | 4.53 Million USD | 82.419% |
| Mitesco, Inc. | 14.13 Million USD | 94.364% |
| MobileSmith, Inc. | 6.15 Million USD | 87.056% |
| NantHealth, Inc. | 384.94 Million USD | 99.793% |
| Net Medical Xpress Solutions, Inc. | 1.07 Million USD | 26.099% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 11.33 Million USD | 92.97% |
| Patient Access Solutions, Inc. | 2.44 Million USD | 67.403% |
| Pharma-Bio Serv, Inc. | 3.77 Million USD | 78.898% |
| PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 88.683% |
| Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | 66.326% |
| Renalytix Plc | 15.82 Million USD | 94.966% |
| Revium Recovery Inc. | 144 Thousand USD | -453.235% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.06 Million USD | 73.988% |
| Vaso Corporation | 48.91 Million USD | 98.371% |
| Vynleads, Inc. | 805.33 Thousand USD | 1.077% |